Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001140361-21-019087
Filing Date
2021-05-27
Accepted
2021-05-27 17:20:10
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-1 nt10023650x4_s1.htm S-1 523665
2 EXHIBIT 5.1 nt10023650x4_ex5-1.htm EX-5.1 9846
3 EXHIBIT 23.1 nt10023650x4_ex23-1.htm EX-23.1 2281
4 EXHIBIT 23.2 nt10023650x4_ex23-2.htm EX-23.2 2624
5 logo_brooklyn.jpg GRAPHIC 97422
6 nt10023650x4_ex5-1img01.jpg GRAPHIC 2279
  Complete submission text file 0001140361-21-019087.txt   677000
Mailing Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220
Business Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220 (212) 582-1199
Brooklyn ImmunoTherapeutics, Inc. (Filer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-256570 | Film No.: 21974204
SIC: 2834 Pharmaceutical Preparations